Skip to content

Medical-device intelligence

QVP: Sars-Cov-2 Serology Test

FDA product code QVP: Sars-Cov-2 Serology Test. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QVP
FDA device name
Sars-Cov-2 Serology Test
Device class
2
Regulation number
866.3983
Medical specialty
Microbiology
Review panel
MI

FDA definition

A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jun 10, 2025 to Apr 13, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202510
January 202600
February 202600
March 202600
April 202610
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QVP · Sars-Cov-2 Serology Test30

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
Elecsys Anti-SARS-CoV-2 SK252280 · QVPRoche Diagnostics510(k)Apr 13, 2026FDA decision date
Elecsys Anti-SARS-CoV-2K253839 · QVPRoche Diagnostics510(k)Dec 17, 2025FDA decision date
Elecsys Anti-SARS-CoV-2K250768 · QVPRoche Diagnostics510(k)Jun 10, 2025FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗